Asymchem Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Public

  • Employees
  • 10,617

Employees

  • Stock Symbol
  • 002821

Stock Symbol

  • Investments
  • 7

  • Share Price
  • $20.49
  • (As of Friday Closing)

Asymchem General Information

Description

Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focus on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Number 6 Dongting 3rd Avenue
  • TEDA
  • Tianjin, 300457
  • China
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
SHE
Vertical(s)
Corporate Office
  • Number 6 Dongting 3rd Avenue
  • TEDA
  • Tianjin, 300457
  • China

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Asymchem Stock Performance

As of 20-Nov-2026, Asymchem’s stock price is $20.49. Its current market cap is $7.21B with 362M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$20.49 $21.18 $12.44 - $29.54 $7.21B 362M 8.9M $0.48

Asymchem Financials Summary

As of 30-Sep-2026, Asymchem has a trailing 12-month revenue of $1.08B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 9,077,212 3,642,051 2,766,343 4,636,396
Revenue 1,078,713 927,532 808,960 1,106,053
EBITDA 172,432 229,029 191,486 405,215
Net Income 171,850 157,491 132,249 320,685
Total Assets 3,227,157 2,898,147 2,642,232 2,788,584
Total Debt 102,842 44,190 44,486 20,773
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Asymchem Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Asymchem‘s full profile, request access.

Request a free trial

Asymchem Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and
Biotechnology
Tianjin, China
10,617 As of 2025

Shanghai, China
 

Bengaluru, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Asymchem Competitors (21)

One of Asymchem’s 21 competitors is Shanghai Medicilon, a Formerly VC-backed company based in Shanghai, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Shanghai Medicilon Formerly VC-backed Shanghai, China
Biocon Formerly PE-Backed Bengaluru, India
ChemPartner Formerly PE-Backed Shanghai, China
Sino Biological Formerly VC-backed Beijing, China
Halloran Consulting Group Private Equity-Backed Cambridge, MA
You’re viewing 5 of 21 competitors. Get the full list »

Asymchem Patents

Asymchem Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026065641-A1 Yarrowia lipolytica yl590 and use thereof Pending 29-Sep-2024
WO-2026020564-A1 Preparation method for saccharopolyspora spinosa spn016 and spinosad and screening method for saccharopolyspora spinosa Pending 25-Jul-2024
WO-2026011779-A1 Method for preparing cemdisiran Pending 10-Jul-2024
WO-2026011783-A1 Method for preparing givosiran Pending 10-Jul-2024
WO-2026011784-A1 Method for preparing lumasiran Pending 10-Jul-2024 C12P19/34
To view Asymchem’s complete patent history, request access »

Asymchem Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Asymchem Investments & Acquisitions (7)

Asymchem’s most recent deal was a Later Stage VC with Xellsmart. The deal was made on 14-Jan-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Xellsmart 14-Jan-2026 Later Stage VC Drug Discovery
Pfizer (Research and Development Laboratory and Production Workshops in Sandwich, England) 22-May-2024 Corporate Asset Purchase Buildings and Property
Bio-Link (Medical Supplies) 01-Nov-2023 Early Stage VC Medical Supplies
Snapdragon Chemistry 09-Sep-2022 Merger/Acquisition BPO/Outsource Services
Yipu Kenuo 17-Dec-2021 Merger/Acquisition Other Healthcare Technology Systems
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Asymchem ESG

Risk Overview

Risk Rating

Updated November, 17, 2026

16.7 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Laboratory Equipment and Services

Subindustry

of 67

Rank

Percentile

To view Asymchem’s complete esg history, request access »

Asymchem Exits (4)

Asymchem’s most recent exit was on 01-Nov-2023 from Bio-Link (Medical Supplies). The exit was categorized as with 10 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Bio-Link (Medical Supplies) 01-Nov-2023 Completed
  • 10 buyers
Guanqin Pharmaceutical 15-Sep-2020 Completed
Snapdragon Chemistry 02-Sep-2020 Corporate Completed
You’re viewing 3 of 4 exits. Get the full list »

Asymchem Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
AsymBio Shanghai, China 2022
Tianjin Youji Medical Tianjin, China 2020
Yipu Kenuo Beijing, China 2015

Asymchem FAQs

  • When was Asymchem founded?

    Asymchem was founded in 1999.

  • Where is Asymchem headquartered?

    Asymchem is headquartered in Tianjin, China.

  • What is the size of Asymchem?

    Asymchem has 10,617 total employees.

  • What industry is Asymchem in?

    Asymchem’s primary industry is Biotechnology.

  • Is Asymchem a private or public company?

    Asymchem is a Public company.

  • What is Asymchem’s stock symbol?

    The ticker symbol for Asymchem is 002821.

  • What is the current stock price of Asymchem?

    As of 20-Nov-2026 the stock price of Asymchem is $20.49.

  • What is the current market cap of Asymchem?

    The current market capitalization of Asymchem is $7.21B.

  • What is Asymchem’s current revenue?

    The trailing twelve month revenue for Asymchem is $1.08B.

  • Who are Asymchem’s competitors?

    Shanghai Medicilon, Biocon, ChemPartner, Sino Biological, and Halloran Consulting Group are some of the 21 competitors of Asymchem.

  • What is Asymchem’s annual earnings per share (EPS)?

    Asymchem’s EPS for 12 months was $0.48.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process